Posted by Clinical Lab Products | Mar 8, 2010 | Cancer, Miscellaneous |
bioTheranostics, a bioMerieux company announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID, and the launch of KRAS mutational testing.
Read MorePosted by Clinical Lab Products | Mar 5, 2010 | Cancer, Miscellaneous |
Abbott announced that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.
Read MorePosted by Clinical Lab Products | Feb 12, 2010 | Cancer, Miscellaneous, Pancreatic |
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read MorePosted by Clinical Lab Products | Dec 11, 2009 | Cancer, Miscellaneous |
The Helen F. Graham Cancer Center associated with Christiana Care Health System will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath assay, an early-stage diagnostic test for lung cancer.
Read MorePosted by Clinical Lab Products | Oct 16, 2009 | Cancer, Miscellaneous |
Prometheus Laboratories Inc announces the nationwide commercial launch of three new cancer diagnostic products, each based on recently developed, highly sensitive microRNA technology.
Read More